Biotech Company Announces Positive Data Results For Alopecia Treatment
Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata.
Disclaimer: This article is for informational purposes only and should not be considered as medical advice. Always consult with a healthcare professional for medical concerns.